Tobii Dynavox Ab (publ) Stock Earnings Reports

Dynavox Group delivered a solid Q1 2026 with revenue of SEK 588 million, representing 15% year‑on‑year growth adjusted for currency (organic growth ~11%, acquisitions ~3%). The quarter was impacted in North America by unusually severe winter weather in January–February that depressed activity and deliveries; March returned to historical growth levels and management expects most of the deferred business to be recovered later in the year. Gross margin was 67% and EBIT was SEK 57 million (EBIT margin 9.8%), showing meaningful margin improvement despite FX headwinds; reported EBIT growth was 56% FX‑adjusted. Cash flow after continuous investments was positive at SEK 56 million, cash on hand SEK 243 million, net debt SEK 865 million and net debt/last‑12m EBITDA ~1.7x. The global ERP rollout is nearly complete, a Stockholm product & solutions hub is fully operational, and the company closed the acquisition of Italian reseller SR Labs Healthcare. Executive changes were announced (new CDIO and COO; CFO will remain through Jan 2027). Management reiterated medium‑term financial targets: average revenue growth of 20% per year (FX‑adjusted) and an annual EBIT margin at or above 15%; the Board proposed a SEK 0.50 per share dividend and a policy to return at least 40% of available net profits when appropriate. Key operational notes: continued investments in sales/IT drove higher OpEx (largely payroll), R&D capitalization and lower restructuring/amortization reduced reported R&D costs versus prior year, and management is prioritizing AI to streamline administrative/reimbursement workflows and internal operations.